PHOENIX, Ariz. (December 16, 2019) — Today, leaders at Vālenz™ announced the appointment of Larry Eisel, CPA, CMA, CGMA, as Chief Financial Officer. In addition to overseeing all financial operations, Eisel will play a key role in strategic planning and establishing sustainable growth goals for Valenz.

Eisel’s background in finance spans more than three decades, including 11 years as CFO for Total Transit, which included Veyo, a healthcare logistics data analytics firm. As such, Eisel brings the right mix of industry experience, financial acumen and leadership strength to the Valenz executive team.

“At Valenz, our promise of smarter, better, faster healthcare requires some of the smartest minds in business, and Larry has the vision and experience we need to lead our enterprise to new heights,” said Rob Gelb, Chief Revenue Officer. “With his prior success in building and managing the finances of growth-oriented companies, I am certain Larry will deliver the results we need to continuously expand our capabilities.”

As a testament to Eisel’s expertise, which includes leadership in mergers and acquisitions, divestitures, risk management, contract management, accounting, compliance, purchasing and more, he was named 2014 CFO of the Year by Financial Executives International. He also received the Outstanding CFO award from the Phoenix Business Journal the same year. Eisel says he is drawn to innovative companies that make a measurable impact by consolidating once-disparate service offerings under one roof, which led him to Valenz and its complete health administrative ecosystem.

“Valenz is extremely well positioned to transform claim management through data science and first-of-its-kind integration, and I am excited to join a team so heavily focused on bringing real savings and solutions to its customers,” Eisel said. “I look forward to the future and doing my part to continually expand the true potential of Valenz.”

About Valenz

Through a complete health administrative ecosystem, Valenz connects cost and quality data on a single-source, end-to-end analytics platform for smarter, better, faster healthcare. Serving self-insured employers, third-party claim administrators, brokers and benefit consultants, trust and labor organizations, stop-loss carriers, integrated healthcare delivery networks, and health/dental plan payers, Valenz solutions integrate data from comprehensive care management services (Valenz Care), high-value provider networks (Valenz Access), claim flow management (Valenz Claim) and solutions for payment integrity, revenue cycle management and eligibility compliance (Valenz Assurance) into the ecosystem. Valenz is backed by Great Point Partners.

About Great Point Partners

Great Point Partners (“GPP”), founded in 2003 and based in Greenwich, CT, is a leading healthcare investment firm, currently with approximately $1.8 billion of equity capital under management and 28 professionals, investing in the United States, Canada and Western Europe. GPP is currently making new private equity investments from GPP III. Great Point manages capital in private (GPP I, $156 million and GPP II, $215 million of committed capital, and GPP III which has $306 million in committed capital) and public (BioMedical Value Fund family, approximately $1.1 billion) equity funds. Great Point Partners has provided growth equity, growth recapitalization and management buyout financing to more than 100 growing healthcare companies. The private equity funds invest across all sectors of the healthcare industry, with particular emphasis on biopharmaceutical services and supplies, outsourcing and alternate site care, pharmaceutical infrastructure and information technology-enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies. Reach Great Point at (203) 971-3300 or www.gppfunds.com.